XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Changes in Equity - USD ($)
shares in Millions, $ in Millions
Total
Ordinary Shares [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Shares [Member]
Total Teva Shareholders' Equity [Member]
Non-controlling Interests [Member]
Beginning balance at Dec. 31, 2020 $ 11,061 $ 57 $ 27,443 $ (10,946) $ (2,399) $ (4,128) $ 10,026 $ 1,035
Beginning balance, shares at Dec. 31, 2020   1,202            
Net Income (loss) 84     77     77 7
Other comprehensive income (loss) (201)       (134)   (134) (67)
Issuance of Shares, shares [1]   6            
Stock-based compensation expense 31   31       31  
Ending balance at Mar. 31, 2021 10,975 $ 57 27,474 (10,869) (2,534) (4,128) 10,000 975
Ending balance, shares at Mar. 31, 2021   1,208            
Beginning balance at Dec. 31, 2021 11,244 $ 57 27,561 (10,529) (2,683) (4,128) 10,278 966
Beginning balance, shares at Dec. 31, 2021   1,209            
Net Income (loss) (952)     (955)     (955) 3
Other comprehensive income (loss) (57)       (4)   (4) (53)
Issuance of Shares, value 1   1       1  
Issuance of Shares, shares [1]   7            
Stock-based compensation expense 24   24       24  
Ending balance at Mar. 31, 2022 $ 10,260 $ 57 $ 27,587 $ (11,484) $ (2,687) $ (4,128) $ 9,344 $ 916
Ending balance, shares at Mar. 31, 2022   1,216            
[1] Represents an amount less than $0.5 million.